Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 Chronic Kidney Disease

NCT05510323 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT05510323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05510323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 Chronic Kidney Disease
Lead sponsor
Air Force Military Medical University, China
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2024
Completion date
August 31, 2028
Enrollment
208 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glomerulonephritis, iga